Puthanakit T, Aurpibul L, Lopez M, Wang M, et al. Efficacy and Safety of the Two-Drug Regimen Dolutegravir/Lamivudine in Adolescents Living With HIV-1 Naive to Antiretroviral Therapy at 48 Weeks (DANCE): A Single-Arm, Open-label, Phase 3b Trial. J Acquir Immune Defic Syndr 2025 Feb 24. doi: 10.1097/QAI.0000000000003655.
PMID: 39988749